-
Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative reviewBurlacu A, Simion P, Nistor I et al. -
Association of Prior Left Ventricular Ejection Fraction With Clinical Outcomes in Patients With Heart Failure With Midrange Ejection FractionA Brann, S Janvanishstaporn, B Greenberg et al.
-
2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight CommitteeHollenberg SM, Warner Stevenson L, Ahmad T
-
The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) StudyIbrahim NE, Januzzi JL Jr.
-
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensusFarmakis D, Agostoni P, Baholli L et al.
-
Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes MellitusK Ejiri, T Miyoshi, MUSCAT‐HF Study Investigators.
-
Circulating sST2 and catestatin levels in patients with acute worsening of heart failure: a report from the CATSTAT-HF studyJA Borovac, D Glavas, ZS Grabovac et al.
-
Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocolHeatley G, Sood P, MOMENTUM 3 Investigators.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
